{"id":"https://openalex.org/W2909155353","doi":"https://doi.org/10.1182/blood-2018-99-115257","title":"Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay","display_name":"Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2909155353","doi":"https://doi.org/10.1182/blood-2018-99-115257","mag":"2909155353"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-115257","doi":"https://doi.org/10.1182/blood-2018-99-115257","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-115257","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012225429","display_name":"Madeline Waldron","orcid":"https://orcid.org/0000-0001-8113-5254","observed_orcids":["https://orcid.org/0000-0001-8113-5254"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Madeline Waldron","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004599506","display_name":"Caitlin Siebenaller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Caitlin Siebenaller","raw_affiliation_strings":["Department of Pharmacy, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110578504","display_name":"Marc A. Earl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marc Earl","raw_affiliation_strings":["Department of Pharmacy, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101184210","display_name":"Xuefei Jia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xuefei Jia","raw_affiliation_strings":["Cancer Biostatistics, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Biostatistics, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016810759","display_name":"Hetty E. Carraway","orcid":"https://orcid.org/0000-0001-5241-3614","observed_orcids":["https://orcid.org/0000-0001-5241-3614"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hetty E. Carraway","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082944296","display_name":"Anjali S. Advani","orcid":"https://orcid.org/0000-0003-0015-5902","observed_orcids":["https://orcid.org/0000-0003-0015-5902"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjali S. Advani","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086233229","display_name":"Aziz Nazha","orcid":"https://orcid.org/0000-0002-6695-7994","observed_orcids":["https://orcid.org/0000-0002-6695-7994"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aziz Nazha","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023728016","display_name":"Aaron Thomas Gerds","orcid":"https://orcid.org/0000-0002-3422-1309","observed_orcids":["https://orcid.org/0000-0002-3422-1309"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron T. Gerds","raw_affiliation_strings":["Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050880000","display_name":"Betty K. Hamilton","orcid":"https://orcid.org/0000-0003-1252-6539","observed_orcids":["https://orcid.org/0000-0003-1252-6539"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty K. Hamilton","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011655907","display_name":"Ronald M. Sobecks","orcid":"https://orcid.org/0000-0003-1608-3261","observed_orcids":["https://orcid.org/0000-0003-1608-3261"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald Sobecks","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112129467","display_name":"Matt E Kalaycio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt Kalaycio","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109418309","display_name":"Barb Tripp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barb Tripp","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002744671","display_name":"Brian Paul Hobbs","orcid":"https://orcid.org/0000-0003-2189-5846","observed_orcids":["https://orcid.org/0000-0003-2189-5846"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brian P. Hobbs","raw_affiliation_strings":["Cancer Biostatistics, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Biostatistics, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102826236","display_name":"Sudipto Mukherjee","orcid":"https://orcid.org/0000-0002-8325-2603","observed_orcids":["https://orcid.org/0000-0002-8325-2603","https://orcid.org/0009-0002-0717-6319"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudipto Mukherjee","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002744671","https://openalex.org/A5004599506","https://openalex.org/A5012225429","https://openalex.org/A5101184210","https://openalex.org/A5110578504"],"corresponding_institution_ids":["https://openalex.org/I1316902750"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"4806","last_page":"4806"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":1.0},{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"acute leukemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/intensive-chemotherapy","display_name":"intensive chemotherapy","score":0.9769999980926514},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.9509999752044678},{"id":"https://openalex.org/keywords/intensive-care-unit-admission","display_name":"intensive care unit admission","score":0.9490000009536743},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9179999828338623},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/promyelocytic-leukemia","display_name":"promyelocytic leukemia","score":0.9020000100135803},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.75},{"id":"https://openalex.org/keywords/peg-asparaginase","display_name":"PEG-asparaginase","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9359999895095825},{"id":"https://openalex.org/keywords/oral-contraceptives","display_name":"oral contraceptives","score":0.75}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8937209844589233},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.6101703643798828},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5704944133758545},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5238682627677917},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.5215518474578857},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4937609136104584},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45701175928115845},{"id":"https://openalex.org/C2776601000","wikidata":"https://www.wikidata.org/wiki/Q612108","display_name":"Acute promyelocytic leukemia","level":4,"score":0.4561828672885895},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43835970759391785},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4367714822292328},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.42040392756462097},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.40128564834594727},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.1392473578453064},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-115257","doi":"https://doi.org/10.1182/blood-2018-99-115257","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-115257","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2740491057","https://openalex.org/W2549891872","https://openalex.org/W2468927803","https://openalex.org/W2980067816","https://openalex.org/W1946859844","https://openalex.org/W2539432718","https://openalex.org/W2980881634","https://openalex.org/W2034085555","https://openalex.org/W7098011061","https://openalex.org/W2053817144"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Patients":[2],"(pts)":[3],"with":[4,92,115,133,169,193,220,326,447,519,548,565,576,607,623],"hematologic":[5],"malignancies":[6],"have":[7,481],"an":[8,59,131,207,655,670,683,721,732,743,754],"increased":[9,553,608],"risk":[10,26,515,554,635],"of":[11,36,53,70,75,95,136,197,223,253,266,274,320,338,360,396,473,521,531,555,560,567,585,600,610,658,673,686,724,735,746,757],"venous":[12],"thromboembolism":[13],"(VTE)":[14],"events,":[15],"driven":[16],"by":[17],"both":[18],"the":[19,34,51,68,86,134,157,244,269,291,297,302,316,321,339,358,466,499,529,583,598,605,620,634],"underlying":[20],"cancer":[21,23],"and":[22,39,46,63,73,109,113,125,130,140,145,233,260,272,283,327,387,408,436,460,491,526,552,570,580,612],"treatment.":[24],"This":[25],"exists":[27],"even":[28,581],"in":[29,33,55,186,332,465,533,574,582,619,639],"acute":[30,96],"leukemia":[31,90,103,234,299],"(AL)":[32],"setting":[35,584],"profound":[37],"thrombocytopenia":[38],"coagulopathies,":[40],"which":[41],"can":[42,615],"delay":[43],"VTE":[44,54,170,200,224,242,314,344,361,397,428,435,443,467,483,508,514,532,561,571,601,638],"diagnosis":[45,94,196,222,362,599],"complicate":[47],"management.":[48],"We":[49],"evaluated":[50],"incidence":[52,273,530,559],"AL":[56,293,340,640],"pts":[57,83,237,280,294,341,368,376,382,389,416,444],"during":[58,243,301,315],"admission":[60,276,614],"for":[61,123,138,141,251,268,637],"chemotherapy":[62,117,164,420],"determined":[64],"its":[65],"effect":[66],"on":[67,215,229,626,654,669,682,720,731,742,753],"duration":[69,472],"hospital":[71],"stay":[72,267,611],"likelihood":[74],"intensive":[76],"care":[77],"unit":[78],"(ICU)":[79],"admission.":[80,246,317,557],"Methods:":[81],"All":[82,199],"admitted":[84,154,295,497],"to":[85,156,236,296,305,476,495,498,502,632],"Cleveland":[87],"Clinic":[88],"inpatient":[89,298],"service":[91,300],"a":[93,194,221,312,470,482,549],"myeloid":[97],"(AML),":[98],"lymphoblastic":[99],"(ALL),":[100],"or":[101,159,189,450,587,660,675,688,726,737,748,759],"promyelocytic":[102],"(APL)":[104],"between":[105,279],"January":[106],"1,":[107],"2013":[108],"March":[110],"31,":[111],"2018":[112],"treated":[114,446],"high-intensity":[116,307],"were":[118,149,153,160,171,212,225,248,277,352,417,445,462,492],"included.":[119],"High":[120],"intensity":[121],"regimens":[122],"AML":[124],"APL":[126,407],"included":[127,143],"infusional":[128],"cytarabine":[129],"anthracycline":[132],"addition":[135],"ATRA":[137],"latter":[139],"ALL":[142],"Hyper-CVAD":[144],"CALBG":[146],"regimens.":[147],"Pts":[148,219,247,464],"excluded":[150],"if":[151,594],"they":[152],"directly":[155],"ICU":[158,275,500,556,613],"transferred":[161],"after":[162,597],"initiating":[163],"from":[165],"another":[166],"institution.":[167],"Cases":[168],"defined":[172],"using":[173],"specific":[174],"ICD-9-CM":[175],"codes":[176],"[451.1x,":[177],"451.2;":[178],"451.81,":[179],"453.1,":[180],"453.2,":[181],"453.8,":[182],"453.9,":[183],"415.1x;":[184],"and,":[185],"addition,":[187],"997.2":[188],"997.3":[190],"when":[191],"coupled":[192],"secondary":[195],"VTE].":[198],"cases":[201],"identified":[202],"through":[203],"this":[204],"strategy":[205],"via":[206],"electronic":[208],"medical":[209],"record":[210],"query":[211],"additionally":[213],"validated":[214],"subsequent":[216],"chart":[217],"review.":[218],"matched":[226,323],"1:3":[227,322],"based":[228],"age,":[230],"sex,":[231],"race,":[232],"subtype":[235],"who":[238,281,284,342,478,504],"did":[239,282,285,479,505],"not":[240,286,480,506,517,563],"experience":[241,287,507],"incident":[245,270],"also":[249],"assessed":[250],"administration":[252],"prothrombotic":[254,522],"agents,":[255],"including:":[256],"PEG-asparaginase,":[257],"oral":[258],"contraceptives,":[259],"tyrosine":[261],"kinase":[262],"inhibitors.":[263],"The":[264,335,558],"length":[265,609],"hospitalization":[271,474,551],"compared":[278,475,501],"VTE.":[288],"Results:":[289],"Of":[290],"400":[292],"study":[303],"period":[304],"receive":[306],"chemotherapy,":[308],"10":[309],"(2.5%)":[310],"had":[311,369,377,383,390,403,406,410,432,439],"documented":[313],"Baseline":[318],"characteristics":[319],"cohorts":[324],"(AL":[325],"without":[328],"VTE)":[329],"are":[330,630],"shown":[331],"Table":[333],"3.":[334],"median":[336,354],"age":[337],"developed":[343],"was":[345,363,423,516,537,546,562],"54.5":[346],"years":[347],"(range,":[348],"20-78":[349],"yrs),":[350],"60%":[351],"females,":[353],"platelet":[355,370],"count":[356],"at":[357],"time":[359],"117,900/mL":[364],"[(range,":[365],"29-476,000/mL);":[366],"4":[367],"(plt)":[371],"counts":[372,579],"below":[373,379],"50,000/mL,":[374],"8":[375,430],"plt":[378,385,578],"100,000/mL;":[380],"2":[381,437,455],"normal":[384,577],"counts],":[386],"four":[388,402],"bloodstream":[391],"infections":[392],"within":[393],"7":[394],"days":[395],"occurrence.":[398],"By":[399,412,427],"disease":[400],"breakdown,":[401],"AML,":[404],"3":[405,409,461],"ALL.":[411],"treatment":[413],"course,":[414],"9":[415],"receiving":[418,424],"initial":[419],"1":[421],"pt":[422],"salvage":[425],"therapy.":[426],"site,":[429],"patients":[431,438,575],"line":[433],"associated":[434,518,547,564],"pulmonary":[440],"embolism.":[441],"Five":[442],"either":[448],"unfractionated":[449],"low":[451],"molecular":[452],"weight":[453],"heparin,":[454],"underwent":[456],"IVC":[457],"filter":[458],"placement":[459],"untreated.":[463],"group":[468],"experienced":[469],"longer":[471],"those":[477,503],"event":[484],"(29.81":[485],"vs":[486,510],"23.13":[487],"days,":[488],"respectively,":[489,512],"P=.027),":[490],"more":[493],"likely":[494],"be":[496],"(66.7%":[509],"14.8%,":[511],"P=.010).":[513],"use":[520,566],"agents":[523,569],"(p=.430).":[524],"Summary":[525],"Conclusion:":[527],"While":[528,590],"our":[534],"patient":[535],"population":[536],"lower":[538],"than":[539],"what":[540],"has":[541],"been":[542],"previously":[543],"reported,":[544],"it":[545,591],"prolonged":[550],"thrombotic":[568],"events":[572],"occurred":[573],"moderate":[586],"severe":[588],"thrombocytopenia.":[589],"is":[592],"unclear":[593],"early":[595],"intervention":[596],"affects":[602],"clinical":[603],"outcome,":[604],"association":[606],"increase":[616],"healthcare-associated":[617],"costs":[618],"current":[621],"environment":[622],"increasing":[624],"focus":[625],"value.":[627],"Further":[628],"studies":[629],"warranted":[631],"characterize":[633],"factors":[636],"population.":[641],"Disclosures":[642],"Carraway:":[643],"Novartis:":[644,698],"Speakers":[645,650,665,678,693],"Bureau;":[646,651,666,679],"FibroGen:":[647],"Consultancy;":[648,699,701,709,712,715],"Jazz:":[649],"Amgen:":[652],"Membership":[653,668,681,719,730,741,752],"entity's":[656,671,684,722,733,744,755],"Board":[657,672,685,723,734,745,756],"Directors":[659,674,687,725,736,747,758],"advisory":[661,676,689,727,738,749,760],"committees;":[662,728,739,750],"Agios:":[663],"Consultancy,":[664],"Balaxa:":[667],"committees,":[677,690],"Celgene:":[680,716,729,740],"Research":[691,696,704],"Funding,":[692],"Bureau.":[694],"Advani:Amgen:":[695],"Funding;":[697],"Glycomimetics:":[700],"Pfizer:":[702],"Honoraria,":[703],"Funding.":[705],"Nazha:MEI:":[706],"Consultancy.":[707,717],"Gerds:Incyte:":[708],"CTI":[710],"Biopharma:":[711],"Apexx":[713],"Oncology:":[714],"Sekeres:Opsona:":[718],"Opsona:":[751],"committees.":[761]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2019-01-25T00:00:00"}